Platelet Production and Function Flashcards
what kind of cells do megakaryotes develop from?
- hematopoietic stem cells
where do hematopoietic stem cells reside?
- in the bone marrow
stem cell gives rise to
- early bilineage progenitors that are able to undergo erythrocyte or megakaryocytic differentiation
Meg-CFCs begin
- endomitosis
what happens in endomitosis
- DNA replication continues
- neither nucleus nor cell undergoes division
what does endomitosis produce?
- a polyploid cell
after endomitosis, what happens with megakaryoctes?
- they undergo cytoplasmic maturation
process of cytoplasmic maturation
- increase in size
- fill with platelet-specific granules
- expand content of cytoskeletal proteins
- develop invaginated membrane system
thrombopoietin function
- the physiologically relevant regulator of platelet production
what is the TPO receptor
- C-Mpl
C-Mpl is located on
- megakaryocytes
- platelets
binding of TPO to its receptor does what
- prevents apoptosis of megakaryocytes
- increases their number, size, and ploidy
additional of TPO to CD34+ cells in culture results in
- majority of cells becoming megakaryocytes
- shedding platelets
synthesis of TPO is
- static
TPO is made in
- the liver
plasma TPO concentrations are regulated by
- platelet production rates
- platelet mass
- MK mass
process of TPO regulation
- platelets and MKs expression c-Mpl receptors that bind and clear TPO from circulation
- thus regulate free TPO levels
integrins are
- heterodimeric transmembrane molecules that cells use to both bind to and respond to extracellular matrix proteins
integrins composed of
- alpha and beta subunits
integrins link
- extracellular matrix
- intracellular cytoskeleton
clustering of integrins leads to
- signaling into the cell
signaling in the cell also causes
- activation of other integrins
major platelet glycoproteins that are integrins
- a2B1
- A2bB3
another name for a2B1
- GPIa-IIa
GPIa-IIa binds
- collagen
another name for a2bB3
- GPIIb-IIIa
GPIIb-IIIa binds
- fibrinogen
platelet glycoproteins that are not integrins
- GP Ib-IX-V
- GPVI
GP Ib-IX-V binds
- von Willebrand factor
GPVI activates
- platelets by binding to collagen
platelet plug formation
- adhesion
- activation
- aggregation
- secretion
adhesion
- platelets stick to injured vessel wall via GP Ib-IX-V (1b-9-5) binding to vWF
activation
- resting platelets come into contact with agonists that bind receptors
- signaling occurs
- platelets change shape, secrete, and activate their GP IIb-IIIa integrins
aggregation
- platelets stick to each other via fibrinogen bridges binding to activated GP IIb-IIIa
secretion
- platelets release granular contents and potentiate clotting
platelet activators examples
- thrombin
- thromboxane
- collagen
- ADP
thrombin receptor
- PAR-1
type of receptor that PAR-1 is
- GPCR
what is the ligand of PAR-1
- it’s own proteolyzed N-terminus
importance of thrombin
- most potent platelet agonist
how is thromboxane produced
- arachidonic acid -> TxA2
- by COX1
COX1 reversibly blocked by
- NSAIDS
COX1 irreversibly blocked by
- aspirin
thromboxane receptor - type of receptor
- GPCR
what keeps the platelets from sticking to normal endothelium?
- nitric oxide
- ecto-ADPase
- prostacyclin
nitric oxide
- vasodilator
Ecto-ADPase
- chews up ADP to prevent platelet activation
how is prostacyclin produced
- arachadonic acid -> prostacyclin
- via COX-1 and COX-2
prostacyclin
- vasodilator
- inhibits platelet activation
membrane of platelets after activation
why?
- turned inside out
- so the negative charges are on the outside
what anchors themselves to the now neg charged platelet membrane?
- coagulation proteins with gamma carboxyl groups
qualitative platelets disorders diagnosed by
- a prolonged bleeding time
- or PFA 100 time
PT in platelet qualitative disorders
- normal
PTT in platelet qualitative disorders
- normal
TT in platelet qualitative disorders
- normal
DDX of qualitative platelet disorders
- congenital
- acquired
DDx of congenital qualitative platelet disorders
- Bernard-Soulier
- Glanzmann’s thrombaesthenia
Bernard-Soulier defect in
- Ib-IX on platelet surface
result of Bernard-Soulier
- no adhesion
Ddx of acquired qualitative platelet disorders
- uremia
- drugs
- herbs
- myeloproliferative diseases
drugs that induce qualitative platelet disorders
- ASA
- NSAIDS
symptoms of platelet dysfunction
- same defects as primary hemostasis
- petechiae
- mucocutaneous bleeding
mucocutaneous bleeding is
- oozing and bruising
mucocutaneous bleeding is NOT
- hematomas
- bleeding into joints
abnormal platelet activation results in
- arterial occlusion
with splenic enlargement and when platelets go there to hang out, what happens with the TPO levels?
- they stay the same
collagen receptors
- GP Ia/IIa
- GP VI
adhesion to collagen mediated by
- GPIa/IIa
GPVI acts in complex with
to cause
- FcR gamma
- platelet activation
ADP released by
- damaged RBCs
ADP secreted by
- activated platelets
ADP receptors
- P2Y12
- P2Y1
type of receptor P2Y12, P2Y1
- GPCR
P2Y12 target of
- anti platelet drugs
Glanzmann’s defect in
- IIb/IIIa
result of Glanzmann’s
- no aggregation